Nanexa AB Overview
Pro stress-test →Nanexa AB is a nanotechnology company specializing in research and development of life science and special systems for drug delivery. The company is transforming long-acting 'super generic' drugs with its proprietary PharmaShell® technology utilizing Atomic Layer Deposition (ALD) technologies.
Strategic Profile
Pro stress-test →Nanexa applies a two-part business model in which the company develops its own product projects, and also enters into cooperation agreements with external pharmaceutical companies for their product projects. The company has collaborations with Novo Nordisk and AstraZeneca for the development of pharmaceutical products with active substances.
Competitive Landscape
Pro stress-test →Nanexa competes in the pharmaceutical drug delivery and long-acting injectable space against established players developing improved GLP-1 formulations and next-generation delivery systems. Key competitive advantages include proprietary ALD coating technology, demonstrated clinical efficacy improvements, and strategic partnerships with major pharma companies (Novo Nordisk, AstraZeneca) that provide both revenue and market validation.
Industry Context
Nanexa AB operates in Pharmaceutical / Biotechnology - Drug Delivery Systems.
Key facts
Founded: 2007 · Headquarters: Uppsala, Sweden